Total Ancillary

What Total Ancillary does

Total Ancillary is a Texas-based, privately held healthcare distribution company that provides end-to-end advanced wound care solutions to U.S. healthcare providers, clinics, hospitals, and wound care clinicians. Founded in 2019 and headquartered in Dallas, the company positions itself as a single-source partner across the full continuum of wound care, from preventive and conservative management through advanced biologic therapies. Its commercial motion combines direct enterprise sales to provider networks with strategic distributor partnerships, notably a February 2026 agreement with XLTA to expand distribution of hydrocapillary wound dressings.

Name

Total Ancillary

Legal name

Total Ancillary

Website

https://totalancillary.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

101–250 employees

Short description

Total Ancillary is a Dallas-based healthcare distribution company providing end-to-end advanced wound care products and services—including biologics, dressings, ultrasound therapy, DME management, and a SaaS platform—to U.S. healthcare providers, clinics, and hospitals.

Ownership category

akta.pro rank

Product category

Advanced Wound Care Distribution

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE)

akta.pro secondary industries

Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG), Wound Closure & Securement (Sutures, Staples, Tissue Adhesives, Skin Closure Strips) (HLAHALAD)

Keywords

• Advanced wound care
• Wound care distribution
• DME management
• Skin substitute management
• Wound care products

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations

Revenue model

1. Wound Care Products Distribution: Distribution of advanced wound care products including XLTA dressings, NovaShield collagen-bioglass matrix, Axolotl amnion membrane allografts, and UltraMIST ultrasound therapy systems.
2. Healthview 360 SaaS Platform: Subscription-based software-as-a-service platform for benefits verification, order management, invoice management, and analytics supporting advanced wound care management.
3. Vista DME Management Services: Full-service DME wound care management solution including product sourcing, logistics, insurance verification, billing support, and reporting services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Total Ancillary distributes a portfolio of advanced wound care products including XLTA hydrocapillary dressings, NovaShield collagen-bioglass wound matrices, UltraMIST noncontact ultrasound therapy, and Axolotl DualGraft human amnion membrane allografts to healthcare providers and clinicians in the U.S. The company also operates Healthview 360, a proprietary SaaS decision support platform for skin substitute management combining benefits verification, order tracking, invoicing, and analytics, alongside VistaDME, a full-service DME wound care management solution covering product sourcing, logistics, insurance verification, billing support, and reporting.

Product overview

Total Ancillary is a Texas-based healthcare distribution company and premier partner in end-to-end advanced wound care solutions. The company operates a platform-plus-products model centered on Healthview 360™ (a proprietary SaaS decision support platform for skin substitute management, benefits verification, order tracking, invoicing, and analytics) combined with a portfolio of clinical products including VistaDME (DME management solution), XLTA® (hydrocapillary wound dressing), NovaShield™ (collagen-bioglass wound matrix), UltraMIST® (noncontact ultrasound therapy), and Axolotl DualGraft™ (human amnion membrane allograft). The platform supports the product portfolio by streamlining ordering, reimbursement, and operational workflows across the wound care continuum.

Differentiator

Problem solved

Functional benefit

Brands

• Healthview 360™: An all-in-one platform for benefits verification, order tracking, invoicing, and analytics – built to streamline every step of advanced wound care. It is Total Ancillary's proprietary decision support platform designed to help providers manage and oversee their wound care programs across the full continuum of care.
• VistaDME
• XLTA
• NovaShield
• UltraMIST
• Axolotl

Products and services

• Healthview 360™ All-in-one SaaS decision support platform for skin substitute management that combines benefits verification, supply chain management, and data analytics to help providers deliver advanced wound care services across the full continuum of care. The platform is HIPAA-compliant and integrates with EMR/EHR systems.
• VistaDME Full-service DME wound care management solution designed to simplify operations through centralized product sourcing, insurance verification, logistics, billing support, reporting, and patient outreach across the entire care and supply lifecycle.
• XLTA® Superabsorbent hydrocapillary wound dressing made from natural fibers designed to manage exudate, prepare wound beds, and support natural healing through a triple-action mechanism including hydrocapillary flow, electrostatic charge for attracting bacteria, cytokines, and MMPs, and proteolytic enzyme balance support.
• NovaShield™ Bovine type I collagen wound matrix combined with 45S5 bioactive glass, designed to support wound management through angiogenesis promotion, inflammation modulation, and MMP activity regulation. The first 510(k) cleared wound product containing collagen plus bioactive glass, with a provisional patent filed.
• UltraMIST® Noncontact low-frequency ultrasound therapy system that delivers ultrasound to the wound using a saline mist without direct wound contact, supporting healing in chronic and acute wounds through pain-free treatment.
• Axolotl DualGraft™ Dehydrated human amnion membrane allograft derived from the amniotic lining of the placenta, indicated as a wound covering and protective structural barrier to support the healing environment. Processed through minimal manipulation techniques, regulated under Section 361 of the PHS Act and 21 CFR Part 1271, manufactured in an AATB-accredited facility, and FDA Tissue Reference Group recommended.

Quantifiable outcome

• Reduction in administrative burden through automated BV validation workflow
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

One partnership is on record.

• XLTAcoreChannel Partner/ Reseller/ Distributor · 4 February 2026Strategic distributor partnership where XLTA, a manufacturer of hydrocapillary wound dressings made from natural fibers, will expand distribution of its chemical-free, non-adherent wound dressing across Total Ancillary's provider and clinician network in the U.S. market. The collaboration aligns with both companies' focus on advanced wound care delivery and clinical relationships.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Organogenesis Holdings: Public pure-play in advanced wound care and skin substitutes (Apligraf, Dermagraft, PuraPly). Directly comparable to Total Ancillary in biologic wound matrix products like NovaShield and amnion grafts like Axolotl, with overlapping hospital and clinic channels.
• MiMedx Group: Leading marketer of dehydrated amnion/chorion membrane allografts (EpiFix, AmnioFix) for wound care and surgical recovery. Directly comparable to Total Ancillary's Axolotl DualGraft product in the Section 361 amnion membrane category.
• Misonix: Specializes in therapeutic ultrasound devices for wound care (SonicOne, TheraSkin-adjacent platforms). Closely comparable to Total Ancillary's UltraMIST noncontact low-frequency ultrasound therapy system targeting chronic and acute wounds.
• Sanara MedTech: Texas-based wound care company combining proprietary biologic products (e.g., CellerateRX), surgical support, and a SaaS/workflow asset (HealthMaker) used by providers. Closely mirrors Total Ancillary's platform-plus-biologic-wound-care model and similar customer base.

Broad incumbents

• Smith+Nephew: Global medical device incumbent with a large advanced wound management portfolio (PICO, ALLEVYN, RENASYS). Competes with Total Ancillary across advanced dressings and biologic-adjacent therapies but at much larger scale and broader portfolio.
• McKesson: Diversified medical distribution and healthcare services company. Comparable to Total Ancillary's distribution-of-wound-care-products model and provider-channel focus, but across all medical specialties and at national scale.
• Cardinal Health: Large medical/surgical distributor supplying wound care products to providers. Comparable to Total Ancillary's distribution-led GTM and provider-network reach, though Cardinal Health operates at vastly larger scale across all med-surg categories.
• Integra LifeSciences: Diversified medtech with a meaningful regenerative tissue and wound care franchise (Integra dermal matrices, amniotic products). Comparable to Total Ancillary's skin substitute and matrix positioning within a broader surgical portfolio.
• ConvaTec: Major wound care and ostomy player (AQUACEL, Foam dressings) with established hospital distribution. Overlaps with Total Ancillary's XLTA dressing line and broader wound care continuum.
• Coloplast: Global wound and skin care company with advanced dressings (Biatain, Comfeel) and adjacent ostomy/continence. Overlaps with Total Ancillary on hydrocapillary/exudate-management dressings like XLTA.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/totalancillary
• Facebookfacebook.com/totalancillary

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Total Ancillary